Company
ChinaYangzhou Aurisco Pharmaceutical Co.,Ltd., China – FDA Inspections
Inspection records and compliance data for Yangzhou Aurisco Pharmaceutical Co.,Ltd.. 2 FDA inspections on record, 1 Form 483, last inspected June 19, 2026.
Company Profile
This profile covers Yangzhou Aurisco Pharmaceutical Co.,Ltd. based in China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected August 11, 2023. Last inspected June 19, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 19, 2026 | Not classified | Human Drugs | 1326202 |
| August 11, 2023 | Not classified | Human Drugs | 1219992 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
NorthStar Medical Radioisotopes, LLC
SMS Pharmaceutical Limited - Unit VII
Syn-Tech Chemical & Pharm. Co., Ltd.
Shandong Anhong Pharmaceutical Co., Ltd.
Symrise, S. de R.L de C.V.
Merck Life Science Technologies (Nantong) Co., Ltd.
SMS Lifesciences India Limited
Reactimex S.A. de C.V.
Jubilant Pharmova Limited
Alexion Pharma International Operations Unlimited Co.
Company Information
Name
Yangzhou Aurisco Pharmaceutical Co.,Ltd.
FEI Number
3021695089
Address
China
Country
China
ID: 0ea3dfec-2357-4631-9b23-a9c72c73098b